Rang	Name	Position
1	Mr. Kevin T. Conroy J.D.	Chairman of the Board, President & CEO
2	Mr. Aaron Bloomer	EVP & CFO
3	Ms. Sarah Condella	Executive Vice President of Human Resources & Service
4	Mr. Jacob Orville MBA	Executive VP & GM of Screening
5	Mr. Brian Baranick	Executive VP & General Manager of Precision Oncology
6	Dr. Jorge A. Garces Ph.D.	Chief Science Officer
7	Mr. Nassar Nizami	Chief Information Officer
8	Derek Leckow	Vice President of Investor Relations
9	Mr. James Herriott	Senior VP, General Counsel & Secretary
10	Mr. Graham P. Lidgard Ph.D.	Emeritus Chief Science Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	9,12%	1,83 Mrd. USD
2	BlackRock Inc	5,53%	1,11 Mrd. USD
3	Pentwater Capital Management LP	3,80%	0,76 Mrd. USD
4	State Street Corp	2,72%	0,55 Mrd. USD
5	Ameriprise Financial Inc	2,35%	0,47 Mrd. USD
6	Balyasny Asset Management LLC	2,14%	0,43 Mrd. USD
7	Millennium Management LLC	1,80%	0,36 Mrd. USD
8	NORGES BANK	1,80%	0,36 Mrd. USD
9	Geode Capital Management, LLC	1,75%	0,35 Mrd. USD
10	Mackenzie Investments	1,44%	0,29 Mrd. USD
11	Massachusetts Financial Services Company	1,43%	0,29 Mrd. USD
12	Beryl Capital Management LLC	1,31%	0,26 Mrd. USD
13	AQR Capital Management LLC	1,17%	0,23 Mrd. USD
14	Qube Research & Technologies	1,06%	0,21 Mrd. USD
15	Tudor Investment Corp Et AL	1,04%	0,21 Mrd. USD
16	Glazer Capital, LLC	0,90%	0,18 Mrd. USD
17	T. Rowe Price Associates, Inc.	0,90%	0,18 Mrd. USD
18	Dimensional Fund Advisors, Inc.	0,84%	0,17 Mrd. USD
19	Renaissance Technologies Corp	0,83%	0,17 Mrd. USD
20	UBS Asset Mgmt Americas Inc	0,83%	0,17 Mrd. USD